Stocktoria
Cellectar Biosciences, Inc. CLRB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2005-05-20
Cellectar Biosciences, Inc. statistics & valuation
Market cap$20.1M
P / B2.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -145.5% | -175.0% | -354.2% | -132.5% | -64.8% |
| Return on equity | -255.2% | -311.9% | 282.1% | -350.8% | -73.0% |
| Current ratio | 2.96 | 2.58 | 0.41 | 3.71 | 9.16 |
Source: SEC EDGAR filings · CIK 0001279704 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.